FDA

Article
Partially Hydrogenated Oil Increasingly Hard to Find as Companies Face Monday Deadline to Eliminate It
Article
FDA, Still Searching for Source of Romaine E Coli Outbreak, Is Hampered by Inadequate Traceability System
Article
Statement of CSPI President Dr. Peter G. Lurie

Resource
Article
CSPI Cites Adulteration, Lack of Effectiveness, and Risk of Bleeding in Letter to FDA

Resource
Article
Statement of CSPI President Dr. Peter G. Lurie
Article
Statement of CSPI Policy Director Laura MacCleery